|
Delayed
Australian S.E.
07:22:50 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.3550 AUD | -4.05% |
|
-4.05% | -45.38% |
| 08-31 | Recce Pharmaceuticals Ltd Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-31 | Recce Pharmaceuticals Ltd Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 113M 81.14M 69.78M 65.84M 59.98M 112M 7.76B 784M 302M 3.93B 305M 298M 12.5B | P/E 2027 * |
-4.35x | P/E 2028 * | 3.33x |
|---|---|---|---|---|---|
| Enterprise Value | 138M 99.04M 85.17M 80.36M 73.21M 137M 9.47B 957M 368M 4.8B 372M 364M 15.25B | EV / Sales 2027 * |
11.1x | EV / Sales 2028 * | 1.2x |
| Free-Float |
62.73% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| RCE | Delayed | |
Deutsche Boerse AG
| R9Q | Delayed | |
|
Börse Stuttgart
| R9Q | Delayed | |
|
Boerse Muenchen
| R9Q | Real-time | |
|
Tradegate
| R9Q | Real-time |
| 1 day | -4.05% | ||
| 1 week | -4.05% | ||
| Current month | -5.33% | ||
| 1 month | -7.79% | ||
| 3 months | -27.55% | ||
| 6 months | -21.98% | ||
| Current year | -45.38% |
| 1 week | 0.34 |  | 0.37 |
| 1 month | 0.34 | | 0.38 |
| Current year | 0.34 | | 0.73 |
| 1 year | 0.34 | | 0.73 |
| 3 years | 0.28 | | 0.73 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/07/26 | Buy | Chief Executive Officer | 25,000 | 0.0083% | ||
| 31/07/26 | Buy | Director | 75,000 | 0.0250% | ||
| 31/07/26 | Buy | Director | 37,500 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.05% | -4.05% | -13.41% | -31.73% | 78.27M | |
| -0.11% | -3.16% | +48.82% | +91.49% | 1,002B | |
| -0.27% | -4.34% | +51.52% | +65.89% | 644B | |
| +1.63% | -2.00% | +20.49% | +71.12% | 443B | |
| -0.63% | -3.09% | +29.84% | +34.59% | 343B | |
| +0.43% | -14.61% | +11.32% | +27.26% | 262B | |
| +0.93% | -3.19% | -1.31% | +8.41% | 245B | |
| -2.25% | -13.88% | +37.33% | +47.43% | 212B | |
| -0.90% | -5.06% | -18.47% | -57.75% | 199B | |
| -0.58% | -4.24% | +25.65% | +90.54% | 181B | |
| Average | -0.51% | -4.80% | +19.18% | +34.72% | 352.98B | |
| Weighted average by Cap. | +0.07% | -4.39% | +31.98% | +57.11% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 12.5M 8.96M 7.71M 7.27M 6.62M 12.38M 857M 86.6M 33.33M 435M 33.65M 32.92M 1.38B | 54.3M 38.94M 33.49M 31.6M 28.79M 53.81M 3.72B 376M 145M 1.89B 146M 143M 6B |
| Net income | -25.1M -18M -15.48M -14.61M -13.31M -24.87M -1.72B -174M -66.95M -873M -67.59M -66.11M -2.77B | 33.4M 23.95M 20.6M 19.44M 17.71M 33.1M 2.29B 231M 89.09M 1.16B 89.95M 87.98M 3.69B |
| Net Debt | 24.96M 17.9M 15.4M 14.53M 13.23M 24.74M 1.71B 173M 66.59M 868M 67.23M 65.76M 2.76B | -48.1M -34.5M -29.67M -27.99M -25.5M -47.67M -3.3B -333M -128M -1.67B -130M -127M -5.31B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | A$0.3550 | -4.05% | 40,381 |
| 10/09/26 | A$0.3700 | +4.23% | 97,134 |
| 09/09/26 | A$0.3550 | -4.05% | 29,672 |
| 08/09/26 | A$0.3700 | +2.78% | 242,532 |
| 07/09/26 | A$0.3600 | -2.70% | 59,963 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
